Salmeterol compared with slow‐release terbutaline in nocturnal asthma A multicenter, randomized, double‐blind, double‐dummy, sequential clinical trial

Allergy

Volumn 49, Issue 6, 1994, Pages 421-426

  Brambilla, C ^a   Chastang, C ^b   Georges, D ^c   Bertin, L ^c   Desfougeres, Dr Jean‐Luc ^d  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Laboratoire GlaxoWellcome   (France)

^d NONE

Author keywords

nocturnal asthma; salmeterol; SR terbutaline

Indexed keywords

CORTICOSTEROID; PLACEBO; SALMETEROL; TERBUTALINE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; TREMOR;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ALBUTEROL; ASTHMA; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; SLEEP; TERBUTALINE;

EID: 0028245991     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1994.tb00834.x     Document Type: Article

References (30)

1. Standard for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
2. Etiology and management of nocturnal asthma
3. Single‐dose slow‐release aminophylline at night prevents nocturnal asthma
4. Validation of morning dip of peak expiratory flow as an indicator of the severity of nocturnal asthma
5. Approaches to a long‐acting selective P2‐adrenoceptor stimulant
6. Salmeterol and salbutamol: large multicentre studies
7. A twelve month comparison of salmeterol with salbutamol in asthmatic patients
8. A single‐dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects
9. Terbutaline sustained‐release tablets in nocturnal asthma. A placebocontrolled comparison between a high and a low evening dose
10. Nocturnal asthma: effect of treatment with oral sustained‐release terbutaline, inhaled budesonide, and the two in combination
11. Nocturnal asthma: effects of slow‐release terbutaline on spirometry and arterial blood‐gases
12. Slowrelease oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels
13. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance
14. 2 agonist
15. Nocturnal asthma: slow‐release terbutaline versus slow‐release theophylline therapy
16. The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other β‐adrenoceptor agonists
17. Exacerbation of asthma in patients on salmeterol
18. Nocturnal events related to “morning dipping” in bronchial asthma
19. Effect of oral slow‐release terbutaline on early morning dyspnoea
20. A comparison of the clinical and bronchodilating effects of plain and slow‐release tablets of terbutaline at steady state
21. Sustained release choline theophyllinate in nocturnal asthma
22. Nocturnal asthma: a model of chronobiologic and pathophysiologic interactions
23. Regular inhaled β‐agonist treatment in bronchial asthma
24. Asthma exacerbation in patients taking regular salmeterol, or salbutamol for symptoms
25. Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma
26. Epidemiology of nocturnal asthma
27. 2‐adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients
28. Inhaled salmeterol improves control in moderate to server asthmatics: a three month study
29. Nocturnal asthma therapy‐inhaled bitolterol versus sustained‐release theophylline